Mode
Text Size
Log in / Sign up
N/A N=108

Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia

TSA · Bruise · Pain, Postoperative

Enrolled (actual)
108
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Numeric Rating Scale Pain Scores at Post-operative Day 14 — 1.6; 3.1 score on a scale

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Surveys (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Hospital for Special Surgery, New York
Primary completion
Dec 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Numeric Rating Scale Pain Scores at Post-operative Day 14
1.6; 3.1
SECONDARY
Numeric Rating Scale (NRS) Pain With Movement and at Rest.
1.6; 2.7; 2.8; 4.7; 2.3; 3.9
SECONDARY
Opioid Consumption (in Past 24 Hours)
17.5; 30; 10
SECONDARY
Opioid Related Symptom Distress Scale
0.3
SECONDARY
Range of Motion
15.8; 35
SECONDARY
Severity of Bruising
1.5
SECONDARY
Hospital Anxiety and Depression Scale
4.1; 3.9
SECONDARY
PainOUT Questionnaire
2; 4; 0; 0; 0; 0
SECONDARY
Pain Catastrophizing Scale (PCS)
12
SECONDARY
Fibromyalgia Scale. a Lower Score is a Better Outcome.
5.5

Summary

This study aims to identify the timeline of pain following total shoulder replacement with the goal of developing data for a subsequent randomized trial. The investigators believe that with using HSS's current protocol, many patients have postoperative pain that is no worse than their preoperative pain. Previous HSS anesthesia protocols for total shoulder arthroplasty patients have not formally followed patients past their hospital discharge, and the investigators believe that some patients do experience moderate to severe subacute postoperative pain. Therefore, this study's primary outcome is to look at the numeric pain scores at 14 days after surgery. Future studies will look at measures of preventing bruising and subsequent pain after shoulder replacement.

Eligibility Criteria

Inclusion Criteria

  • All patients eligible for the standardized anesthetic for TSA
  • Patients who are capable to provide informed consent and answer questions in English (Study involves questionnaires validated in English)
  • Age 18-80

Exclusion Criteria

  • Incapable to provide informed consent
  • Contraindications for regional anesthesia (anticoagulation, infection at injection site)
  • Patients undergoing TSA for Trauma or Rheumatoid Arthritis
  • Revision TSA (previous non-TSA surgery is not an exclusion)
  • Conversion of hemiarthroplasty to TSA
  • Planned use of tranexamic acid
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03021096). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search